Policy Archives | Page 2 of 15

A Look at Disparities Across Cancer Care

A new AACR report tracks progress in addressing cancer health disparities and identifies work that still needs to be done.

by Eric Fitzsimmons

Policy Matters

Patient Advocacy Is Driving Change

Patient advocates strengthen every aspect of research, from funding innovative science and informing research design, to leading efforts on Capitol Hill to build support for research.

by Carrie Treadwell, MBA

Understanding Stress and Cancer

A symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.

by Eric Fitzsimmons

The Impact of the RACE for Children Act

Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.

by Marci A. Landsmann

Medicaid: A Partial Safety Net

Expansions in coverage and eligibility through the Affordable Care Act have made Medicaid a lifeline for many people with cancer, but benefits vary from state to state.

by Sharon Tregaskis

Forward Look

Adequate Representation

Medical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.

by Erin O'Donnell

Policy Matters

Cancer Research: The Key to Tomorrow’s Cures

The AACR is engaging with Congress and the Biden administration on the importance of funding for cancer research.

by David A. Tuveson, MD, PhD

Facts and Stats

Fifty Years of Growing Survivorship

More people in the U.S. are alive after being diagnosed with cancer than ever before.

by Eric Fitzsimmons

Oncology Takes on Cannabis

People take cannabis to treat an array of cancer-related symptoms and side effects. Legal prohibitions have stymied attempts at research into cannabis in cancer patients, but doctors are finding creative ways to study its effects.

by Kate Yandell